Benutzer: Gast  Login
Dokumenttyp:
journal article 
Autor(en):
Wagner, U; du Bois, A; Pfisterer, J; Huober, J; Loibl, S; Lück, HJ; Sehouli, J; Gropp, M; Stähle, A; Schmalfeldt, B; Meier, W; Jackisch, C; AGO Ovarian Cancer Study Group 
Titel:
Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6). 
Abstract:
BACKGROUND: Tamoxifen and gefitinib (IRESSA) combination therapy was studied in patients with ovarian cancer refractory or resistant to platinum- and taxane-based therapy. PATIENTS AND METHODS: In this phase II study, 56 patients with epithelial ovarian carcinoma or cancer of the fallopian tube or peritoneum received oral tamoxifen 40 mg/day and gefitinib 500 mg/day until progression or unacceptable toxicity. RESULTS: Seventeen patients (mean age: 59.6 years) had previously received first-line p...    »
 
Zeitschriftentitel:
Gynecol Oncol 
Jahr:
2007 
Band / Volume:
105 
Heft / Issue:
Seitenangaben Beitrag:
132-7 
Sprache:
eng 
Print-ISSN:
0090-8258 
TUM Einrichtung:
Frauenklinik und Poliklinik